Understanding confidence in the human papillomavirus vaccine in Japan: a web-based survey of mothers, female adolescents, and healthcare professionals

References

• Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, De Sanjosé S. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human papillomavirus and related diseases in Japan. Summary report 17 June 2019. [accessed 2020 Apr 26]. http://www.hpvcentre.net/statistics/reports/JPN.pdf?t=1546657739790.
   Google Scholar
• Gallagher KE, LaMontagne DS, Watson-Jones D. Status of HPV vaccine introduction and barriers to country uptake. Vaccine. 2018;36(32):4761–67. doi:10.1016/j.vaccine.2018.02.003.
   PubMed Web of Science ®Google Scholar
• Drolet M, Benard E, Pérez N, Brisson M; HPV Vaccination Impact Study Group. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497–509. doi:10.1016/S0140-6736(19)30298-3.
   Web of Science ®Google Scholar
• Konno R, Konishi H, Sauvaget C, Ohashi Y, Kakizoe T. Effectiveness of HPV vaccination against high grade cervical lesions in Japan. Vaccine. 2018;36(52):7913–15. doi:10.1016/j.vaccine.2018.05.048.
   PubMed Web of Science ®Google Scholar
• Kudo R, Yamaguchi M, Sekine M, Adachi S, Ueda Y, Miyagi E, Hara M, Hanley SJB, Enomoto T. Bivalent human papillomavirus vaccine effectiveness in a Japanese population: high vaccine-type-specific effectiveness and evidence of cross-protection. J Infect Dis. 2019;219(3):382–90. doi:10.1093/infdis/jiy516.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Yaegashi N, Iwata T, Yamamoto K, Aoki Y, Okadome M, Ushijima K, Kamiura S, Takehara K, Horie K, et al. Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program. Cancer Sci. 2019;110(12):3811–20. doi:10.1111/cas.14212.
   Web of Science ®Google Scholar
• Yagi A, Ueda Y, Ikeda S, Sekine M, Nakayama T, Miyagi E, Enomoto T. Evaluation of future cervical cancer risk in Japan, based on birth year. Vaccine. 2019;37(22):2889–91. doi:10.1016/j.vaccine.2019.04.044.
   PubMed Web of Science ®Google Scholar
• Hanley SJ, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan. Lancet. 2015;385(9987):2571. doi:10.1016/S0140-6736(15)61152-7.
   PubMed Web of Science ®Google Scholar
• Simms KT, Hanley SJB, Smith MA, Keane A, Canfell K. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. Lancet Public Health. 2020;5(4):e223–e234. doi:10.1016/S2468-2667(20)30010-4.
   PubMed Web of Science ®Google Scholar
• Larson HJ, De Figueiredo A, Xiahong Z, Schulz WS, Verger P, Johnston IG, Cook AR, Jones NS. The state of vaccine confidence 2016: global insights through a 67-country survey. EBioMedicine. 2016;12:295–301. doi:10.1016/j.ebiom.2016.08.042.
   PubMed Web of Science ®Google Scholar
• Larson HJ, Schulz WS, Tucker JD, Smith DMD. Measuring vaccine confidence: introducing a global vaccine confidence index. PLoS Curr. 2015;7:ecurrents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4.
   Google Scholar
• Paterson P, Meurice F, Stanberry LR, Glismann S, Rosenthal SL, Larson HJ. Vaccine hesitancy and healthcare providers. Vaccine. 2016;34(52):6700–06. doi:10.1016/j.vaccine.2016.10.042.
   PubMed Web of Science ®Google Scholar
• Wilson AR, Hashibe M, Bodson J, Gren LH, Taylor BA, Greenwood J, Jackson BR, She R, Egger MJ, Kepka D. Factors related to HPV vaccine uptake and 3-dose completion among women in a low vaccination region of the USA: an observational study. BMC Womens Health. 2016;16(1):41. doi:10.1186/s12905-016-0323-5.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Safety update of HPV vaccine. Extract from report of GACVS meeting of 7–8 June 2017. [accessed 2020 Apr 22]. https://www.who.int/vaccine_safety/committee/topics/hpv/June_2017/en/.
   Google Scholar
• Ministry of Health, Labour and Welfare. A joint meeting of the Vaccine Adverse Reactions Review Committee (VARRC). in Japanese. [accessed 2020 Apr 22]. https://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000147016.pdf.
   Google Scholar
• Suzuki S, Hosono A. No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: results of the Nagoya study. Papillomavirus Res. 2018;5:96–103. doi:10.1016/j.pvr.2018.02.002.
   PubMed Web of Science ®Google Scholar
• Iwata S, Okada K, Kawana K; Expert Council on Promotion of Vaccination. Consensus statement from 17 relevant Japanese academic societies on the promotion of the human papillomavirus vaccine. Vaccine. 2017;35(18):2291–92. doi:10.1016/j.vaccine.2017.03.015.
   PubMed Web of Science ®Google Scholar
• Larson HJ. Japan’s HPV vaccine crisis: act now to avert cervical cancer cases and deaths. Lancet Public Health. 2020;5(4):e184–e185. doi:10.1016/S2468-2667(20)30047-5.
   Web of Science ®Google Scholar
• Health and Global Policy Institute. 2018 Survey on healthcare in Japan. October 2018 [accessed 2020 Apr 29]. https://hgpi.org/wp-content/uploads/6f80b9e850a48391e02d6cc166fba1ee.pdf.
   Google Scholar
• Katsuta T, Moser CA, Offit PA, Feemster KA. Japanese physicians’ attitudes and intentions regarding human papillomavirus vaccine compared with other adolescent vaccines. Papillomavirus Res. 2019;7:193–200. doi:10.1016/j.pvr.2019.04.013.
   PubMed Web of Science ®Google Scholar
• Sawada M, Ueda Y, Yagi A, Morimoto A, Nakae R, Kakubari R, Abe H, Egawa-Takata T, Iwamiya T, Matsuzaki S, et al. HPV vaccination in Japan: results of a 3-year follow-up survey of obstetricians and gynecologists regarding their opinions toward the vaccine. Int J Clin Oncol. 2018;23(1):121–25. doi:10.1007/s10147-017-1188-9.
   PubMed Web of Science ®Google Scholar
• Kobayashi KI, Chanyasanha C, Sujirarat D. Parental decision-making on human papillomavirus vaccination for daughters in Japan. Int J Adolesc Med Health. 2020. doi:10.1515/ijamh-2018-0140.
   PubMedGoogle Scholar
• Shiomi M, Ueda Y, Abe H, Yagi A, Sakiyama K, Kimura T, Tanaka Y, Ohmichi M, Ichimura T, Sumi T, et al. A survey of Japanese mothers on the effectiveness of the Ministry of Health, Labor and Welfare’s revised HPV vaccine leaflet. Hum Vaccin Immunother. 2020;16(10):2555–58. doi:10.1080/21645515.2020.1723362.
   PubMed Web of Science ®Google Scholar
• Larson HJ. Why trust in doctors isn’t enough to change people’s minds: the case of HPV vaccination in Japan. BMJ. 2020 [accessed 2020 Dec 16]. https://blogs.bmj.com/bmj/2020/03/27/why-trust-in-doctors-isnt-enough-to-change-peoples-minds-the-case-of-hpv-vaccination-in-japan/.
   PubMed Web of Science ®Google Scholar
• Bratic JS, Seyferth ER, Bocchini JA Jr. Update on barriers to human papillomavirus vaccination and effective strategies to promote vaccine acceptance. Curr Opin Pediatr. 2016;28(3):407–12. doi:10.1097/MOP.0000000000000353.
   PubMed Web of Science ®Google Scholar
• INTAGE, Inc. Survey monitor. (In Japanese). [accessed 2018 Dec 19]. https://www.intage.co.jp/english/service/platform/monitor/.
   Google Scholar
• PLAMED, Inc. Survey monitor. (In Japanese). [accessed 2018 Dec 19]. https://www.plamed.co.jp/business/index.php.
   Google Scholar